Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
7.42
-0.20 (-2.62%)
At close: May 30, 2025, 4:00 PM
7.29
-0.13 (-1.75%)
After-hours: May 30, 2025, 4:12 PM EDT
CRBP Market Cap
CRBP has a market cap or net worth of $91.41 million as of May 30, 2025. Its market cap has decreased by -80.05% in one year.
Market Cap
91.41M
Enterprise Value
-36.69M
1-Year Change
-80.05%
Ranking
Category
Stock Price
$7.42
Market Cap Chart
Since November 11, 2014, CRBP's market cap has increased from $75.80M to $91.41M, an increase of 20.59%. That is a compound annual growth rate of 1.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 93.20M | -35.14% |
| Dec 31, 2024 | 143.70M | 438.20% |
| Dec 29, 2023 | 26.70M | 93.48% |
| Dec 30, 2022 | 13.80M | -82.10% |
| Dec 31, 2021 | 77.10M | -26.57% |
| Dec 31, 2020 | 105.00M | -70.26% |
| Dec 31, 2019 | 353.10M | 5.62% |
| Dec 31, 2018 | 334.30M | -14.19% |
| Dec 29, 2017 | 389.60M | 3.75% |
| Dec 30, 2016 | 375.50M | 505.65% |
| Dec 31, 2015 | 62.00M | -19.58% |
| Dec 31, 2014 | 77.10M | 1.72% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 651.06B |
| Johnson & Johnson | 368.73B |
| AbbVie | 328.06B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 267.61B |
| Abbott Laboratories | 231.29B |
| Novartis AG | 221.98B |
| AstraZeneca | 219.74B |